$1.2 Million Distributed by Mary Kay Ash Foundation Will Fund Promising Cancer Researchers at Top Universities Advancing Cures For Women-Related Cancers Dr. Howe, an assistant professor of ...
NORTH CHICAGO, Ill., Oct. 23, 2024 /PRNewswire/ -- U.P. Oncolytics, a company in Rosalind Franklin University's Helix 51 biomedical incubator, has been awarded Orphan Drug designation by the FDA's ...
NORTH CHICAGO, Ill., Jan. 23, 2025 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announced that Monopar Therapeutics is the latest biotech company to join the Helix 51 ...
NORTH CHICAGO, Ill., June 25, 2025 /PRNewswire/ -- UP Oncolytics, a neuro-oncology biotechnology company based in Milwaukee and a spin-out of the Advocate Aurora Research Institute, has received a $75 ...
NORTH CHICAGO, Ill., May 1, 2025 /PRNewswire/ -- BLR Bio, a biotechnology company in Rosalind Franklin University's Helix 51 incubator, announced new data on its novel therapy for systemic sclerosis ...
Rosalind Franklin University is picking up about $9.8 million in funding from the National Institutes of Health for three research projects, the North Chicago life sciences university said in a press ...
NORTH CHICAGO, Ill., Feb. 4, 2021 /PRNewswire/ — The $50 million Innovation and Research Park on the campus of Rosalind Franklin University of Medicine and Science marked its first anniversary with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback